FDA NDA · NDA012515

KENACORT

Sponsor: DELCOR ASSET CORP

APPLICATION

NDA012515

TYPE

NDA

ORIGINAL APPROVAL

1961-03-21

LATEST ACTION

2009-03-13

ROUTE

ORAL

DOSAGE FORM

SYRUP

MARKETING STATUS

Discontinued

Products

KENACORTDiscontinued

TRIAMCINOLONE DIACETATE EQ 4MG BASE/5ML · SYRUP · ORAL

2009-03-13Labeling · Supplement 18AP

2009-03-13Labeling · Supplement 16AP

2009-03-13Labeling · Supplement 10AP

1993-09-07Labeling · Supplement 21AP

1982-06-30Manufacturing (CMC) · Supplement 19 · standardAP

1979-08-21Manufacturing (CMC) · Supplement 17 · standardAP

1979-07-17Manufacturing (CMC) · Supplement 15 · standardAP

1978-11-02Labeling · Supplement 12AP

1961-03-21Type 5 - New Formulation or New Manufacturer · Original · standardAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.